Amoxicillin and Clavulanate Potassium
Name(s): Clavamox Tablets (pfizer)
CLAVAMOX® Tablets are indicated in the treatment of:
Clavamox for Dogs: Skin and
soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile
and deep pyoderma due to susceptible strains of the following organisms:
b-lactamase-producing Staphylococcus aureus, non-b-lactamase-producing
Staphylococcus aureus, Staphylococcus spp., Streptococcus spp.,
and E. coli. Periodontal infections due to susceptible strains of
both aerobic and anaerobic bacteria. CLAVAMOX® has been shown
to be clinically effective for treating cases of canine periodontal
Clavamox for Cats: Skin and
soft tissue infections such as wounds, abscesses, and cellulitis/dermatitis
due to susceptible strains of the following organisms: b-lactamase-producing
Staphylococcus aureus, non-b-lactamase-producing taphylococcus aureus,
Staphylococcus spp., Streptococcus spp., E. coli, and Pasteurella
spp. Urinary tract infections (cystitis) due to susceptible strains
of E. coli. Therapy may be initiated with CLAVAMOX® prior to
obtaining results from bacteriological and susceptibility studies.
A culture should be obtained prior to treatment to determine susceptibility
of the organisms to CLAVAMOX®. Following determination of susceptibility
results and clinical response to medication, therapy may be reevaluated.
Clavamox should be used: Dosage and Administration:
Clavamox for Dogs: The recommended
dosage is 6.25 mg/lb of body weight twice a day.Skin and soft tissue
infections such as abscesses, cellulitis, wounds, superficial/juvenile
pyoderma, and periodontal infections should be treated for 5-7 days
or for 48 hours after all symptoms have subsided. If no response
is seen after 5 days of treatment, therapy should be
discontinued and the case reevaluated. Deep pyoderma may require
treatment for 21 days; the maximum duration of treatment should
not exceed 30 days.
Clavamox for Cats: The recommended
dosage is 62.5 mg twice a day. Skin and soft tissue infections such
as abscesses and
cellulitis/dermatitis should be treated for 5-7 days or for 48 hours
after all symptoms have subsided, not to exceed 30 days. If no response
is seen after 3 days of treatment, therapy should be discontinued
and the case reevaluated.
Urinary tract infections may require treatment for 10-14 days or
CLAVAMOX® (amoxicillin trihydrate/clavulanate potassium) is
an orally administered formulation comprised of the
broad-spectrum antibiotic Amoxi® (amoxicillin trihydrate) and
the b-lactamase inhibitor, clavulanate potassium (the potassium
salt of clavulanic acid).
Side effects of Clavamox may include loss of appetite,
nausea, vomiting and diarrhea. If an allergic reaction occurs, symptoms
include rash, fever, swelling of face or limbs, difficulty breathing,
rapid heart beat and incoordination.